Pluribus Labs’s Carlyle Group CG Stock Holding History

Pluribus Labs’s Portfolio CG Stock Details CG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$219K	Buy	+6,913	New	+$265K	0.4%	85

Other funds holding CG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pluribus Labs's CG Position: Q2 2022 in Review

Pluribus Labs opened a new position in Carlyle Group (CG) in Q2 2022: 6,913 shares worth $219K. The stake represents 0.4% of the portfolio and ranks #85 among its holdings.

443 funds tracked by Wall St. Rank hold CG as of Q2 2022.

Pluribus Labs held 6,913 shares of Carlyle Group worth $219K as of Q2 2022.
Carlyle Group was a new Pluribus Labs position in Q2 2022.
Carlyle Group made up 0.4% of Pluribus Labs's portfolio in Q2 2022, its #85 holding.
443 funds tracked by Wall St. Rank held Carlyle Group as of Q2 2022.

Based on Pluribus Labs's 13F filing for Q2 2022, filed 12 Aug 2022.